- $55.42m
- $88.73m
- $59.32m
- 36
- 48
- 80
- 54
Annual income statement for Vivakor, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 1.46 | 1.09 | 28.1 | 59.3 |
Cost of Revenue | |||||
Gross Profit | 0 | 0.101 | 0.038 | 2.87 | 5.02 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1.7 | 6.31 | 8.01 | 50.9 | 65.7 |
Operating Profit | -1.7 | -4.85 | -6.93 | -22.7 | -6.33 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.69 | -2.4 | -8.31 | -24.7 | -10.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.27 | -2.87 | -7.26 | -20.2 | -10.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2.16 | -2.18 | -5.48 | -19.4 | -10.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.16 | -2.36 | -5.53 | -19.4 | -10.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -268 | -199 | -0.466 | -0.763 | -0.572 |